Glopisine

Glopisine is a prescription oral medication that contains the active ingredient finasteride, a 5‑alpha‑reductase inhibitor. It is marketed in the European Union and supplied as tablets (strength not specified). Finasteride reduces the conversion of testosterone to dihydrotestosterone (DHT), which underlies its use in certain prostate and hair‑loss conditions.

Glopisine is indicated for two primary therapeutic areas that involve androgen‑dependent processes.

- Treatment of benign prostatic hyperplasia (BPH) in adult men to improve urinary flow and reduce prostate size. - Management of male pattern hair loss (androgenetic alopecia) to promote hair regrowth and slow further loss. - May be prescribed as part of a comprehensive BPH management plan that includes lifestyle and other pharmacologic measures. - Used under medical supervision for patients who meet specific diagnostic criteria for the above conditions.

Finasteride can cause a range of side effects, most of which are mild and reversible. Serious adverse events are less common but require medical attention.

Common: - Decreased libido or sexual desire. - Erectile dysfunction. - Reduced ejaculate volume. - Breast tenderness or enlargement. - Rash or mild skin irritation. - Dizziness or headache.

Serious: - Allergic reactions such as swelling of the face, lips, or throat. - Persistent breast pain or lumps. - Signs of depression or mood changes. - Testicular pain. - Severe liver enzyme abnormalities (rare).

Before starting Glopisine, certain health considerations should be reviewed with a healthcare professional.

- Not recommended for use in women or children; pregnancy category X due to risk of fetal abnormalities. - Men with a history of prostate cancer should discuss potential risks and benefits. - Patients with liver impairment may require monitoring of liver function tests. - Caution is advised in individuals with a history of depression or low mood. - Regular follow‑up is recommended to assess treatment response and any emerging side effects. - Inform the prescriber of any concurrent use of hormonal therapies or supplements.

Finasteride may interact with other medications, altering its effectiveness or increasing the risk of adverse effects.

Avoid: - Concomitant use of strong CYP3A4 inhibitors (e.g., ketoconazole) that could increase finasteride plasma levels. - Hormonal agents such as testosterone replacement therapy that may counteract the drug’s mechanism.

Use with caution: - Anticoagulants or antiplatelet drugs, as rare bleeding disorders have been reported. - Other 5‑alpha‑reductase inhibitors (e.g., dutasteride) due to additive hormonal effects. - Medications that affect liver metabolism, requiring periodic liver function monitoring. - Herbal supplements like saw palmetto, which also influence DHT pathways.